Mast Cells and the Host Response in the Lung

肥大细胞和肺中的宿主反应

基本信息

  • 批准号:
    7244388
  • 负责人:
  • 金额:
    $ 35.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-07-02 至 2009-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long-term objective of our research is to determine the mechanisms by which mast cells regulate the host response to bacterial lung infections and to be able to modify how mast cells coordinate this response in ways that benefit the host. Recently, we made the discovery that the mast cell protease dipeptidyl peptidase I (DPPI) contributes to death of the host from septic peritonitis and that it appears to do so by regulating levels of mast cell IL-6. This suggests that mast cell DPPI, or other mast cell proteins regulated by DPPI, modify the host response to bacterial infection in ways that harm the host. Our central hypothesis is that: Mast cell proteases and cytokines coordinate lung defense against bacterial infections. While coordinating this defense, some of these mediators protect the host and improve survival while others harm the host and worsen survival. Specific aims are: #1. To determine the mechanism by which mast cell DPPI modulates the host response and survival from bacterial lung infections. This will be accomplished by applying a new method for creating mast cell-specific knockout mice and determining the physiologic mechanism for survival following inoculation with Klebsiella pneumoniae. #2. To define mechanisms by which mast cell proteases regulate cytokine levels during bacterial infections. We will test whether mast cell proteases hydrolyze cytokines by incubating cytokines with purified DPPI, tryptase or chymase and identifying cleavage products. Protease mediated cytokine production will be studied by measuring cytokines released by specific lung cells in response to DPPI, tryptase or chymase. #3. To determine whether mast cell TNF-alpha, IL-6, or IL-10 modulate the host response and survival from bacterial lung infections. We will use mast cell-specific-TNF-alpha, -IL-6, or -IL-10 knockout mice to test if mast cell sources of these cytokines play important roles in host defense. By understanding how specific mast cell mediators regulate host defense, we will gain greater insight into how these cells influence host survival. This knowledge can then be applied to the development of new treatments for bacterial pneumonia that modulate the activity of specific mast cells proteins in ways that improve survival.
描述(申请人提供):我们研究的长期目标是确定肥大细胞调节宿主对细菌肺部感染的反应的机制,并能够改变肥大细胞如何以有利于宿主的方式协调这种反应。最近,我们发现肥大细胞蛋白酶二肽基肽酶I(DPPI)参与了感染性腹膜炎宿主的死亡,并且似乎是通过调节肥大细胞IL-6的水平来实现的。这表明肥大细胞DPPI或其他受DPPI调控的肥大细胞蛋白以损害宿主的方式改变了宿主对细菌感染的反应。我们的中心假设是:肥大细胞蛋白酶和细胞因子协调肺对细菌感染的防御。在协调这种防御的同时,这些介体中的一些保护宿主并提高存活率,而另一些则伤害宿主并恶化存活率。具体目标是:#1.确定肥大细胞DPPI调节宿主反应和细菌肺部感染存活的机制。这将通过应用一种新的方法来创建肥大细胞特异性基因敲除小鼠,并确定接种肺炎克雷伯菌后存活的生理机制。2.确定肥大细胞蛋白水解酶在细菌感染过程中调节细胞因子水平的机制。我们将通过将细胞因子与纯化的DPPI、类胰蛋白酶或糜酶孵育并鉴定切割产物来测试肥大细胞蛋白水解酶是否能降解细胞因子。将通过测量特定肺细胞对DPPI、类胰蛋白酶或糜酶的反应释放的细胞因子来研究蛋白酶介导的细胞因子的产生。#3.确定肥大细胞TNF-α、IL-6或IL-10是否调节宿主对细菌性肺部感染的反应和存活。我们将使用肥大细胞特异性的-TNF-α、-IL-6或-IL-10基因敲除小鼠来测试这些细胞因子的肥大细胞来源是否在宿主防御中发挥重要作用。通过了解特定的肥大细胞介质如何调节宿主防御,我们将更深入地了解这些细胞如何影响宿主生存。然后,这些知识可以应用于细菌性肺炎的新治疗方法的开发,以提高存活率的方式调节特定肥大细胞蛋白的活性。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paul j WOLTERS其他文献

Paul j WOLTERS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paul j WOLTERS', 18)}}的其他基金

Lung Remodeling Mediated by Telomere Dysfunction in Alveolar Type II Cells
II 型肺泡细胞端粒功能障碍介导的肺重塑
  • 批准号:
    10660570
  • 财政年份:
    2018
  • 资助金额:
    $ 35.91万
  • 项目类别:
Lung fibrosis mediated by telomere dysfunction in alveolar type II cells
II型肺泡细胞端粒功能障碍介导的肺纤维化
  • 批准号:
    10200132
  • 财政年份:
    2018
  • 资助金额:
    $ 35.91万
  • 项目类别:
Analysis of Alveolar Type II cells in Normal and Fibrotic Human Lung
正常和纤维化人肺中 II 型肺泡细胞的分析
  • 批准号:
    8113080
  • 财政年份:
    2011
  • 资助金额:
    $ 35.91万
  • 项目类别:
Analysis of Alveolar Type II cells in Normal and Fibrotic Human Lung
正常和纤维化人肺中 II 型肺泡细胞的分析
  • 批准号:
    8249365
  • 财政年份:
    2011
  • 资助金额:
    $ 35.91万
  • 项目类别:
Mast Cells and the Host Response in the Lung
肥大细胞和肺中的宿主反应
  • 批准号:
    6917109
  • 财政年份:
    2004
  • 资助金额:
    $ 35.91万
  • 项目类别:
Mast Cells and the Host Response in the Lung
肥大细胞和肺中的宿主反应
  • 批准号:
    7088884
  • 财政年份:
    2004
  • 资助金额:
    $ 35.91万
  • 项目类别:
Mast Cells and the Host Response in the Lung
肥大细胞和肺中的宿主反应
  • 批准号:
    6820426
  • 财政年份:
    2004
  • 资助金额:
    $ 35.91万
  • 项目类别:
MAST CELL CYSTEINE PROTEASES IN LUNG INFLAMMATION
肺部炎症中的肥大细胞半胱氨酸蛋白酶
  • 批准号:
    6388547
  • 财政年份:
    1999
  • 资助金额:
    $ 35.91万
  • 项目类别:
MAST CELL CYSTEINE PROTEASES IN LUNG INFLAMMATION
肺部炎症中的肥大细胞半胱氨酸蛋白酶
  • 批准号:
    2881397
  • 财政年份:
    1999
  • 资助金额:
    $ 35.91万
  • 项目类别:
MAST CELL CYSTEINE PROTEASES IN LUNG INFLAMMATION
肺部炎症中的肥大细胞半胱氨酸蛋白酶
  • 批准号:
    6183187
  • 财政年份:
    1999
  • 资助金额:
    $ 35.91万
  • 项目类别:

相似海外基金

Can antibiotics disrupt biogeochemical nitrogen cycling in the coastal ocean?
抗生素会破坏沿海海洋的生物地球化学氮循环吗?
  • 批准号:
    2902098
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Studentship
Metallo-Peptides: Arming Cyclic Peptide Antibiotics with New Weapons to Combat Antimicrobial Resistance
金属肽:用新武器武装环肽抗生素以对抗抗菌素耐药性
  • 批准号:
    EP/Z533026/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Research Grant
The role of RNA repair in bacterial responses to translation-inhibiting antibiotics
RNA修复在细菌对翻译抑制抗生素的反应中的作用
  • 批准号:
    BB/Y004035/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Research Grant
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
  • 批准号:
    EP/Y023528/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Research Grant
Towards the sustainable discovery and development of new antibiotics
迈向新抗生素的可持续发现和开发
  • 批准号:
    FT230100468
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    ARC Future Fellowships
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
  • 批准号:
    BB/Y007611/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Research Grant
The disulfide bond as a chemical tool in cyclic peptide antibiotics: engineering disulfide polymyxins and murepavadin
二硫键作为环肽抗生素的化学工具:工程化二硫多粘菌素和 murepavadin
  • 批准号:
    MR/Y033809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Research Grant
Role of phenotypic heterogeneity in mycobacterial persistence to antibiotics: Prospects for more effective treatment regimens
表型异质性在分枝杆菌对抗生素持久性中的作用:更有效治疗方案的前景
  • 批准号:
    494853
  • 财政年份:
    2023
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Operating Grants
Imbalance between cell biomass production and envelope biosynthesis underpins the bactericidal activity of cell wall -targeting antibiotics
细胞生物量产生和包膜生物合成之间的不平衡是细胞壁靶向抗生素杀菌活性的基础
  • 批准号:
    2884862
  • 财政年份:
    2023
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Studentship
Narrow spectrum antibiotics for the prevention and treatment of soft-rot plant disease
防治植物软腐病的窄谱抗生素
  • 批准号:
    2904356
  • 财政年份:
    2023
  • 资助金额:
    $ 35.91万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了